Charles N. Bernstein

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD

G. Kaplan, A. Griffiths, A. Bitton, 2018, Journal of the Canadian Association of Gastroenterology.

Clinical Practice Guideline for the Management of Luminal Crohn's Disease: The Toronto Consensus.

P. Moayyedi, A. Bitton, C. Bernstein, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease

P. Moayyedi, A. Bitton, C. Bernstein, 2018, Journal of the Canadian Association of Gastroenterology.

Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation

G. Kaplan, R. Panaccione, K. MacDonald, 2024, Therapeutic advances in chronic disease.

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care

G. Kaplan, A. Bitton, C. Bernstein, 2018, Journal of the Canadian Association of Gastroenterology.

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn’s and Colitis Canada

G. Kaplan, A. Griffiths, A. Bitton, 2018, Journal of the Canadian Association of Gastroenterology.

The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary

G. Kaplan, A. Bitton, N. Rohatinsky, 2023, Journal of the Canadian Association of Gastroenterology.

Crohn's Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study.

G. Kaplan, Z. Nugent, L. Graff, 2024, Inflammatory bowel diseases.

Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.

H. Steinhart, A. Bitton, R. Enns, 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.